Chimeric antigen receptor T (CAR T) cell therapy represents a milestone in leukemia treatment. CAR T works by genetically ...
New ASH guidelines outline optimal management for a subgroup of patients with leukemia that historically has been challenging to treat.Two papers published simultaneously in Blood Advances address ...
News-Medical.Net on MSN
Biomimetic platform enhances CAR T therapy for relapsed and refractory leukemia
Chimeric antigen receptor T (CAR T) cell therapy represents a milestone in leukemia treatment. CAR T works by genetically engineering a chimeric antigen receptor on the surface of the patient's T ...
Chimeric antigen receptor T (CAR T) cell therapy represents a milestone in leukemia treatment. CAR T works by genetically engineering a chimeric ...
Stocktwits on MSN
SLS stock rallies ahead of AML trial readout — 'Pharma Bro' Martin Shkreli says he's still 'very bearish,' predicts drug will fail
The debate centers on Sellas’ Phase 3 Regal trial, which is testing its immunotherapy Galinpepimut-S (GPS) as a maintenance treatment for AML patients. ・The readout is nearing a key trigger, with ...
Asianet Newsable on MSN
SLS stock falls premarket: CEO touts GPS leukemia strategy, but investors stay cautious as AML trial nears readout
The CEO said Sellas is pursuing a “security force” immunotherapy strategy that trains immune cells to recognize cancer even as tumors evolve.
Blackstone Inc. (NYSE:BX) is one of the best undervalued stocks to invest in right now. Barclays cut the price target on Blackstone Inc. (NYSE:BX) to $126 from $164 on March 2, maintaining an Equal ...
8NewsNow.com on MSN
Colon Cancer Awareness with Intermountain Health
March is Colon Cancer Awareness month. According to a study published in January 2026 by the Journal of American Medical Association, colorectal cancer is now the leading cause of cancer-related death ...
An oncologist explains the situations when doctors recommend getting screened for colorectal cancer before age 45.
Findings from a phase 1/2 trial (NCT04176) presented at the 2025 American Society of Hematology Annual Meeting and Exposition ...
Early-phase clinical trials involving PIM-1 kinase inhibitors look promising. In the evolving landscape of myelofibrosis (MF) ...
Fred Hutch Cancer Center hematologists took center stage at the 2026 Tandem Meetings, a multidisciplinary meeting of experts in the field of blood stem cell transplantation, held in Salt Lake City ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results